Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

RDY

Dr Reddys Laboratories (RDY)

Dr Reddys Laboratories Ltd
일자:
정렬 기준:
 검색 관련기사 보기:NYSE:RDY
일자시간출처헤드라인심볼기업
2025/03/2419:24Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:RDYDr Reddys Laboratories Ltd
2025/03/2203:40Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:RDYDr Reddys Laboratories Ltd
2025/03/1821:35Business WireAlvotech and Dr. Reddy’s Announce FDA Acceptance of Biologic License Application for AVT03, a Proposed Biosimilar to Prolia® and Xgeva®NYSE:RDYDr Reddys Laboratories Ltd
2025/03/1821:30GlobeNewswire Inc.Alvotech and Dr. Reddy’s Announce FDA acceptance of Biologic License Application for AVT03, a Proposed Biosimilar to Prolia® and Xgeva®NYSE:RDYDr Reddys Laboratories Ltd
2025/03/1402:36Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:RDYDr Reddys Laboratories Ltd
2025/03/1220:52Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:RDYDr Reddys Laboratories Ltd
2025/03/0801:02Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:RDYDr Reddys Laboratories Ltd
2025/03/0621:33Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:RDYDr Reddys Laboratories Ltd
2025/03/0320:16Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:RDYDr Reddys Laboratories Ltd
2025/02/2521:43Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:RDYDr Reddys Laboratories Ltd
2025/02/1501:35Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:RDYDr Reddys Laboratories Ltd
2025/02/1221:53Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:RDYDr Reddys Laboratories Ltd
2025/02/1220:08Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:RDYDr Reddys Laboratories Ltd
2025/02/0623:30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:RDYDr Reddys Laboratories Ltd
2025/02/0621:51Business WireDr. Reddy’s enters into collaboration with Henlius for commercialization of HLX15 (daratumumab), a biosimilar candidate to Darzalex® & Darzalex Faspro® in the U.S., and EuropeNYSE:RDYDr Reddys Laboratories Ltd
2025/02/0521:07Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:RDYDr Reddys Laboratories Ltd
2025/02/0422:34Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:RDYDr Reddys Laboratories Ltd
2025/02/0422:31Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:RDYDr Reddys Laboratories Ltd
2025/02/0420:09Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:RDYDr Reddys Laboratories Ltd
2025/02/0320:10Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:RDYDr Reddys Laboratories Ltd
2025/01/3002:41Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:RDYDr Reddys Laboratories Ltd
2025/01/2921:13Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:RDYDr Reddys Laboratories Ltd
2025/01/2503:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:RDYDr Reddys Laboratories Ltd
2025/01/2502:50Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:RDYDr Reddys Laboratories Ltd
2025/01/2420:43Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:RDYDr Reddys Laboratories Ltd
2025/01/2420:41Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:RDYDr Reddys Laboratories Ltd
2025/01/2405:21Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:RDYDr Reddys Laboratories Ltd
2025/01/2403:50Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:RDYDr Reddys Laboratories Ltd
2025/01/2402:35Business WireDr. Reddy’s Q3 & 9MFY25 Financial ResultsNYSE:RDYDr Reddys Laboratories Ltd
2025/01/2303:39Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:RDYDr Reddys Laboratories Ltd
 검색 관련기사 보기:NYSE:RDY